Bafna Pharmaceuticals Share Price
30 Oct, 2026 3:15 PM (IST)
Bafna Pharmaceuticals Performance
- Today's Low
- ₹448
- Today's High
- ₹457
- 52 Week Low
- ₹95
- 52 Week High
- ₹480
- Open Price₹457
- Previous Close₹457
- Volume10,019
- 50 DMA₹370.90
- 100 DMA₹309.30
- 200 DMA₹244.60
Bafna Pharmaceuticals Chart
Investment Returns
- Over 1 Month + 23%
- Over 3 Month + 73.77%
- Over 6 Month + 239.73%
- Over 1 Year + 218.09%
Smart Investing Starts Here Start SIP with Bafna Pharmaceuticals for Steady Growth!
Bafna Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 136.1
- PEG Ratio
- -23.5
- Market Cap Cr
- 1,060
- P/B Ratio
- 11
- Average True Range
- 8.8
- EPS
- 3.3
- Dividend Yield
- 0
- MACD Signal
- 28
- RSI
- 67.05
- MFI
- 56.61
Latest Stock News Updates
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
- BSE India
- 2 weeks 4 days ago
Intimation for Closure of Trading Window
- BSE India
- 1 month ago
We herewith enclose the Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report.
- BSE India
- 1 month 2 weeks ago
Bafna Pharmaceuticals Financials
Bafna Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹427.10
- 50 Day
- ₹370.90
- 100 Day
- ₹309.30
- 200 Day
- ₹244.60
Resistance and Support
- R3 463.10
- R2 460.00
- R1 454.00
- S1 444.90
- S2 441.80
- S3 435.80
Bafna Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-08-11 | Quarterly Results | |
| 2026-05-29 | Audited Results | |
| 2026-02-11 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-12 | Quarterly Results |
About Bafna Pharmaceuticals
Bafna Pharmaceuticals is engaged in the business of manufacturing of finished pharmaceutical formulations. View More- NSE Symbol
- BAFNAPH
- BSE Symbol
- 532989
- ISIN
- INE878I01022
Similar Stocks to Bafna Pharmaceuticals
Popular Stocks
Bafna Pharmaceuticals FAQs
Bafna Pharmaceuticals share price is ₹447 As on 31 October, 2026 | 11:46
The Market Cap of Bafna Pharmaceuticals is ₹1059.6 Cr As on 31 October, 2026 | 11:46
The P/E ratio of Bafna Pharmaceuticals is 136.1 As on 31 October, 2026 | 11:46
The PB ratio of Bafna Pharmaceuticals is 11 As on 31 October, 2026 | 11:46
The 52 week High & Low of Bafna Pharmaceuticals is ₹480/₹94.8 respectively As on 31 October, 2026 | 11:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.